AngioDynamics

AngioDynamics Enterprise Value

The Enterprise Value (EV) of AngioDynamics (ANGO) as of Sep 20, 2026 is 398.29 M USD. In the previous year, Enterprise Value (EV) was 402.46 M USD — a change of -1.04% (lower).

Enterprise Value

398.29 MUSD

YoY

-1.04%

Last updated:

Enterprise Value (EV) of AngioDynamics is 2026 398.29 M USD. Enterprise Value (EV) of AngioDynamics was 2025 402.46 M USD. It decreases by -1.04% lower compared to the previous year.

The AngioDynamics Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
356.41 M USD
Jan 1, 2020
437.72 M USD
Jan 1, 2021
423.99 M USD
Jan 1, 2022
448.33 M USD
Jan 1, 2023
457.33 M USD
Jan 1, 2024
376.10 M USD
Jan 1, 2025
402.46 M USD
Jan 1, 2026
398.29 M USD
The AngioDynamics Enterprise Value history
YEAREnterprise ValueYoY
398.29 MUSD-1.04%
402.46 MUSD+7.01%
376.10 MUSD-17.76%
457.33 MUSD+2.01%
448.33 MUSD+5.74%
423.99 MUSD-3.14%
437.72 MUSD+22.81%
356.41 MUSD-23.90%
468.34 MUSD-6.27%
499.70 MUSD-7.24%
538.67 MUSD-5.46%
569.77 MUSD-1.24%
576.94 MUSD
Access this data via the Eulerpool API

AngioDynamics Stock analysis

What does AngioDynamics do? AngioDynamics Inc is a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company was founded in 1988 and is headquartered in Latham, New York. Over the years, AngioDynamics has evolved into a conglomerate through several acquisitions and partnerships, specializing in various areas. The key divisions include Vascular Access Solutions, Oncology Solutions, and Peripheral Vascular Solutions. AngioDynamics focuses on developing and manufacturing innovative technologies that improve medical care and promote patient health. The company develops and distributes a wide range of medical devices and procedures to treat diseases such as cancer, venous diseases, and thrombosis. In the Vascular Access Solutions division, AngioDynamics offers a wide range of devices for establishing vascular access, which are necessary for the treatment of serious illnesses. This includes port systems and catheters that facilitate access to the body's vascular system. AngioDynamics' Oncology Solutions provide targeted cancer treatment options, including ultrasound-controlled radiofrequency ablation systems and fusion biopsy systems. The development of innovative diagnostic and treatment options is a focus of AngioDynamics. A majority of AngioDynamics' products are in the Peripheral Vascular Solutions division. Here, the company develops devices and procedures for the treatment of peripheral vascular diseases such as varicose veins or chronic venous insufficiency. This includes procedures like laser and radiofrequency treatments that can be performed minimally invasively. AngioDynamics has gained an excellent reputation in the medical industry due to its high-quality products, innovative technologies, and close collaboration with medical professionals. The company places great emphasis on providing optimal care to every patient and therefore serves hospitals, clinics, and medical practices worldwide. Over the years, AngioDynamics has become a leading provider of medical devices and solutions for the treatment of vascular diseases and cancer. The company has built a broad customer base worldwide and has become an important player in the medical industry due to the quality and innovation of its products. AngioDynamics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AngioDynamics stock

Enterprise Value (EV) of AngioDynamics is 398.29 M USD in 2026.

Enterprise Value (EV) of AngioDynamics changed from 402.46 M USD to 398.29 M USD, representing a -1.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) AngioDynamics since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s AngioDynamics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — AngioDynamics

All Key Metrics — AngioDynamics